Mar 21 2020

Pharmaceutical Microbiology, pharma blog.

#Pharma #blog

Pharmaceutical Microbiology

Microbiology, pharmaceuticals, healthcare and contamination control news and discussion site. Edited by Dr. Tim Sandle (established 2010)


Pharma blog

Wednesday, 22 November 2017

Justification of starting materials for the manufacture of chemical active substances

Pharma blog

Tuesday, 21 November 2017

Q Pharmig20 and you or your company will be invoiced accordingly.

Microbial Control of Pharmaceutical Water Systems

Pharma blog

Sunday, 19 November 2017

Biocidal cleaners may spread multidrug resistance in MRSA

Pharma blog

Saturday, 18 November 2017

Examining the lifestyles of microbes

Pharma blog

Friday, 17 November 2017

Bacterial signalling in sharper resolution

Pharma blog

Thursday, 16 November 2017

ISO/IEC 17025 moves to final stage of revision

Pharma blog

Wednesday, 15 November 2017

Past, present, and future perspectives on the LAL reagent

Q A covering past, present, and future perspectives on the LAL reagent

Pharma blog

JD: Actually, we use all four methods: gel-clot, kinetic turbidimetric, kineticchromogenic and the PTS . These methods are used to test and release incoming raw materials and to evaluate intermediate formulation buffers that are subsequently used to produce licensed LAL products. Our accessory products also benefit from the use of these methods prior to release. Finally, we leverage all of these techniques in developing and validating LAL test methods for customer-specific products.

How did the introduction of the LAL test change our industry?

What are the key trends in endotoxin and LAL testing? What advances have been made?

What new challenges will be faced in the years to come?

Written by admin